Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome

Prostaglandins Leukot Med. 1985 Jun;18(3):401-2. doi: 10.1016/0262-1746(85)90073-3.
No abstract available

MeSH terms

  • Epoprostenol / metabolism*
  • Erythrocyte Deformability
  • Humans
  • Kidney / metabolism
  • Raynaud Disease / blood*
  • Scleroderma, Systemic / blood*

Substances

  • Epoprostenol